The International Journal of Tuberculosis and Lung Disease

The ethics of national tuberculosis programmes in low-income countries not rolling out Xpert ® MTB/RIF
pp. 1563-1563(1)
Authors: Singh, Jerome Amir; Bhan, Anant

Still missing the boat for care of people living with asthma: when will we get it right?
pp. 1564-1564(1)
Author: Enarson, Donald A.

Are Year-in-Review articles useful for the International Journal of Tuberculosis and Lung Disease?
pp. 1565-1565(1)
Authors: Yew, Wing-Wai; Borgdorff, Martien W.; Enarson, Donald A.

Contact tracing in low-incidence tuberculosis settings
pp. 1566-1566(1)
Authors: van Leth, Frank; Borgdorff, Martien

Xpert^® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
pp. 1567-1572(6)
Authors: Trébucq, A.; Enarson, D.A.; Chiang, C.Y.; Van Deun, A.; Harries, A.D.; Boillot, F.; Detjen, A.; Fujiwara, P.I.; Graham, S.M.; Monedero, I.; Rusen, I.D.; Rieder, H.L.

Hermann Michael Biggs and tuberculosis as a public health concern
pp. 1572-1573(2)
Author: Daniel, T.M.

Asthma programmes in diverse regions of the world: challenges, successes and lessons learnt
pp. 1574-1587(14)
Authors: Lalloo, U.G.; Walters, R.D.; Adachi, M.; de Guia, T.; Emelyanov, A.; Fritscher, C.C.; Hong, J.; Jimenez, C.; King, G.G.; Lin, J.; Loaiza, A.; Nadeau, G.; Neffen, H.; Sekerel, B.E.; Yorgancıoğlu, A.; Zar, H.J.

A systematic review of economic evaluation studies of tuberculosis control in high-income countries
pp. 1587-1598(12)
Authors: Verdier, J.E.; de Vlas, S.J.; Baltussen, R.; Richardus, J.H.

2010: The year in review, Part II. What new knowledge about tuberculosis did we gain through the IJTLD?
pp. 1598-1607(10)
Authors: Chiang, C-Y.; Chee, C.B.E.

Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring
pp. 1608-1614(7)
Authors: Rao, C.; Kosen, S.; Bisara, D.; Usman, Y.; Adair, T.; Djaja, S.; Suhardi, S.; Soemantri, S.; Lopez, A.D.

Programmatic impact of using QuantiFERON^® -TB Gold in routine contact investigation activities
pp. 1614-1620(7)
Authors: Grinsdale, J.A.; Ho, C.S.; Banouvong, H.; Kawamura, L.M.

A rapid assessment of prevailing policies on tuberculosis contact investigation
pp. 1620-1623(4)
Authors: Hwang, T.J.; Ottmani, S.; Uplekar, M.

Indeterminate QuantiFERON^® -TB Gold results in a public health clinic setting
pp. 1623-1630(8)
Authors: Banach, D.B.; Harris, T.G.

Coverage and yield of tuberculosis contact investigations in the Netherlands
pp. 1630-1637(8)
Authors: Mulder, C.; van Deutekom, H.; Huisman, E.M.; Meijer-Veldman, W.; Erkens, C.G.M.; van Rest, J.; Borgdorff, M.W.; van Leth, F.

Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau
pp. 1637-1643(7)
Authors: Gomes, V.F.; Wejse, C.; Oliveira, I.; Andersen, A.; Vieira, F.J.; Carlos, L.J.; Vieira, C.S.; Aaby, P.; Gustafson, P.

Prevalence and risk factors for tuberculosis infection among personnel in two hospitals in Viet Nam
pp. 1643-1649(7)
Authors: Powell, K.; Han, D.; Hung, N.V.; Vu, T.; Sy, D.N.; Trinh, T.T.; Le, T.C.; Do, K.; Oeltmann, J.E.; Whitehead, S.

Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions
pp. 1649-1657(9)
Authors: Lehloenya, R.J.; Todd, G.; Badri, M.; Dheda, K.

Impact of smear microscopy results and observed therapy on tuberculosis treatment in Mombasa, Kenya
pp. 1656-1663(8)
Authors: Arentz, M.; Narita, M.; Sangaré, L.; Kah, J.F.; Low, D.; Mandaliya, K.; Amukoye, E.; Sitienei, J.; Walson, J.L.

Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi
pp. 1663-1669(7)
Authors: Kumwenda, M.; Tom, S.; Chan, A.K.; Mwinjiwa, E.; Sodhi, S.; Joshua, M.; van Lettow, M.

Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China
pp. 1669-1675(7)
Authors: Lan, R.; Yang, C.; Lan, L.; Ou, J.; Qiao, K.; Liu, F.; Gao, Q.

Neuromyelitis optica and pulmonary tuberculosis: a case-control study
pp. 1675-1680(6)
Authors: Zatjirua, V.; Butler, J.; Carr, J.; Henning, F.

Rapid molecular identification of mycobacterial species in positive culture isolates using the biochip test
pp. 1680-1685(6)
Authors: Pang, Y.; Zhou, Y.; Wang, S.; Tan, Y.; Yue, J.; Zhao, B.; Wang, L.; Zhao, Y.; Kam, K.M.

Molecular characterisation of isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Central Tunisia
pp. 1685-1688(4)
Authors: Kahla, I. Ben; Marzouk, M.; Henry, M.; Bedotto, M.; Cohen-Bacrie, S.; Selma, W. Ben; Boukadida, J.; Drancourt, M.

Study of KIR genes in Lebanese patients with tuberculosis
pp. 1688-1691(4)
Authors: Mahfouz, R.; Halas, H.; Hoteit, R.; Saadeh, M.; Shamseddeen, W.; Charafeddine, K.; Itani, L.; Araj, G.F.

Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada
pp. 1691-1698(8)
Authors: Tan, W.C.; Bourbeau, J.; FitzGerald, J.M.; Cowie, R.; Chapman, K.; Hernandez, P.; Buist, S.A.; Sin, D.D.

Compliance with the CURB-65 score and the consequences of non-implementation
pp. 1697-1702(6)
Authors: Guo, Q.; Li, H-Y.; Zhou, Y-P.; Li, M.; Chen, X-K.; Liu, H.; Peng, H-L.; Yu, H-Q.; Chen, X.; Liu, N.; Liang, L-H.; Zhao, Q-Z.; Jiang, M.

Costs of admission for paediatric pneumonia in a setting of human immunodeficiency virus infection
pp. 1702-1707(6)
Authors: Kitchin, O.P.; Wessels, F.; Masekela, R.; Becker, P.; Green, R.J.

Pulmonary nodules detected by thoracic computed tomography scan after exposure to asbestos: diagnostic significance
pp. 1707-1714(8)
Authors: Clin, B.; Luc, A.; Morlais, F.; Paris, C.; Ameille, J.; Brochard, P.; De Girolamo, J.; Gislard, A.; Laurent, F.; Letourneux, M.; Schorle, E.; Launoy, G.; Pairon, J-C.

The impact of antiretroviral treatment programs on tuberculosis notification rates
pp. 1714-1715(2)
Authors: Middelkoop, Keren; Wood, Robin; Bekker, Linda-Gail

In reply
pp. 1714-1715(2)
Authors: Zachariah, R.; Gomani, P.; Massaquoi, M.; Harries, A.D.